Artemisone NEW
| Price | $47 | $103 | $163 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-10 |
Product Details
| Product Name: Artemisone | CAS No.: 255730-18-8 |
| Purity: 99.90% | Supply Ability: 10g |
| Release date: 2025/11/10 |
Product Introduction
Bioactivity
| Name | Artemisone |
| Description | Artemisone (BAY 44-9585) is a potent and semi-synthetic antimalarial, inhibits P. falciparum strains (IC50: 0.83 nM). It also is a potent inhibitor of human CMV. |
| In vitro | Artemisone inhibits 3D7 and K1 P. falciparum with IC50 values of 0.88±0.59 nM and 1.23±0.64 nM, respectively. |
| In vivo | Artemisone, when administered subcutaneously at doses of 3, 1, 0.3, and 0.1 mg/kg in conjunction with other antimalarials, demonstrates an enhanced effectiveness against the chloroquine-resistant P. yoelii NS strain[1]. Moreover, it is effective at inhibiting parasitemia in the P. berghei NY susceptible strain, achieving an ED50 of 9.62 mg/kg through the subcutaneous route and 11.67 mg/kg when given orally[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (9.96 mM), Sonication is recommended. DMSO : 130 mg/mL (323.77 mM), Sonication is recommended. |
| Keywords | Parasite | P. falciparum | Inhibitor | inhibit | Cytomegalovirus | CMV | Artemisone |
| Inhibitors Related | Flubendazole | Phenytoin sodium | Kojic acid | Urethane | Hydroxychloroquine | Metronidazole | 2-Amino-2-methyl-1-propanol | Doxycycline | L-Lysine | Fenpyroximate | Thymidine | Coumaran |
| Related Compound Libraries | Anti-Parasitic Compound Library | Failed Clinical Trials Compound Library | Bioactive Compound Library | ReFRAME Related Library | Inhibitor Library | NO PAINS Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-Infection Compound Library | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $47.00/1mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-11-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY